- By Saul Levin, M.D., M.P.A., FRCP-E, FRCPsych
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to monitor prescribing and dispensing of the drug, which is used to treat schizophrenia. The new REMS led to confusion for manufacturers, pharmacies, prescribers, and patients. Some clinicians stopped prescribing the already underutilized drug, and some pharmacies stopped dispensing it. This chaotic situation led the FDA to stop enforcing certain requirements of the REM for 90 days.
March is Women’s History Month and we’re highlighting several women currently leading the organization: APA President Vivian Pender, M.D., President-Elect Rebecca W. Brendel, M.D., J.D., and Assembly Speaker Mary Jo Fitz-Gerald, M.D., M.B.A.
Because of changes to the election guidelines in effect this year that are designed to even the playing field, APA helped to produce some additional materials about the candidates.
Several American Psychiatric Association (APA) courses, offered through SMI Adviser, cover ways to promote well-being among patients, whether though exercise, connecting with others, or positivity.
The Mental Health Needs of Those Impacted by the End of the War in Afghanistan Continue: Resources for Ongoing Efforts
As tens of thousands of evacuees from Afghanistan continue to be resettled across the U.S. this winter, anticipating and responding to their mental health needs remain paramount.